Avi Levin

Avi Levin

Auto-generated profile, based on publicly available information

Avi Levin

Department of Endodontics, Israel Defense Forces, Medical Corps, Tel Hashomer, Israel

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2012 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
Uri KopylovUri Kopylov
Uri Kopylov
ALA. Levin
A. Levin
EME. Mendelson
E. Mendelson
SDS. Dovrat
S. Dovrat
MBM. Book
M. Book
SBS. Ben‐Horin
S. Ben‐Horin
Summary: Background: Varicella zoster virus (VZV) is a severe and preventable infection in immunosuppressed IBD patients. ECCO guidelines recommend VZV immunisation in patients with negative VZV exposure history. The value of patient‐reported VZV exposure history for prediction of seropositivity in IBD patients remains unknown. Moreover, data on VZV immunity in adult IBD patients or accuracy of VZV serological testing under immunomodulator treatment is sparse.Aims: The primary aim was to determine the prevalence of seropositivity for VZV‐IgG in immunomodulator‐treated IBD patients. A secondary aim was to establish the value of patient‐reported history of past VZV infection for prediction of immunity, to validate the current vaccination strategy.Methods: History of VZV‐related illness was accessed by epidemiological questionnaire, and serological testing for VZV‐IgG was performed. Serum anti‐TNF medications levels were measured when applicable.Results: One hundred twenty one IBD (86% Crohn's disease, mean age 37 ± 12.8) patients were included in the study. Immunomodulator therapy was received by 87% (anti‐TNFs‐ 71%) of the patients. Previous exposure to VZV was reported by 104 patients, and 97/104 (93%) were VZV‐IgG seropositive. Seventeen patients, all seropositive, reported negative exposure history. The calculated positive and negative predictive values for the reported history of VZV exposure were 93% and 0% respectively.Conclusions: Negative history of VZV exposure is a poor predictor of seronegativity. History‐positive patients may still be seronegative and exposed to VZV infection. We suggest serological testing of all IBD patients with subsequent immunisation of the seronegative patients before initiation of immunosuppressive therapy.

14 June 2010 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
ALAvi Levin
Avi Levin
YMYair Morad
Yair Morad
BNBen gurion university of the negev
Ben gurion university of the negev
MRMordechai Ravid
Mordechai Ravid
YBYosefa Bar-Dayan
Yosefa Bar-Dayan

1 December 2015 in Journal of Endodontics
Verified
Journal Article
Closed access
PDF file
ALAvi Levin
Avi Levin
ASAvi Shemesh
Avi Shemesh
VKVered Katzenell
Vered Katzenell
AGAyelet Gottlieb
Ayelet Gottlieb
JIJoe Ben Itzhak
Joe Ben Itzhak
MSMichael Solomonov
Michael Solomonov

19 October 2010 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
ALAvi Levin
Avi Levin
JLJoseph Lysy
Joseph Lysy